Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly

• Published in: European journal of endocrinology Vol. 150; no. 1; pp. 27 - 32
• Main Authors: Arosio, M, Ronchi, CL, Gebbia, C, Pizzinelli, S, Conte, D, Cappiello, V, Epaminonda, P, Cesana, BM, Beck-Peccoz, P, Peracchi, M
• Format: Journal Article
• Language: English
• Published: Colchester European Society of Endocrinology 01-01-2004; Portland Press
• Subjects: Acromegaly - blood; Acromegaly - drug therapy; Adrenocorticotropic Hormone - blood; Adult; Aged; Biological and medical sciences; Blood Glucose; Clinical Studies; Endocrinopathies; Female; Fundamental and applied biological sciences. Psychology; Ghrelin; Hormones - blood; Human Growth Hormone - blood; Humans; Hydrocortisone - blood; Hypothalamus. Hypophysis. Epiphysis (diseases); Insulin - blood; Male; Medical sciences; Middle Aged; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Pancreas - metabolism; Pancreatic Polypeptide - blood; Peptide Hormones - administration & dosage; Pituitary Gland - metabolism; Prolactin - blood; Somatostatin - blood; Vertebrates: endocrinology; Endocrinopathy; Pituitary hormone; Pancreatic hormone; Ghrelin; Pituitary diseases; Diseases of the osteoarticular system; Acromegaly; Endocrinology
• ISSN: 0804-4643; 1479-683X
• DOI: 10.1530/eje.0.1500027

OBJECTIVE: Ghrelin, a gut-brain peptide involved in the control of energy homeostasis, affects antero-pituitary and gastro-entero-pancreatic (GEP) hormone secretion in healthy subjects. We aimed to verify whether such hormonal responses are retained in acromegaly, a disease characterized by high GH, subnormal ghrelin and abnormal GEP hormone levels. DESIGN AND METHODS: The effect of ghrelin (3.3 microg/kg given after overnight fasting as an i.v. bolus) on GH, prolactin (PRL), adrenocorticotropin (ACTH), cortisol, insulin, glucose, total somatostatin (SS) and pancreatic polypeptide (PP) circulating levels were evaluated in seven non-diabetic patients with newly diagnosed acromegaly and in nine healthy controls. RESULTS: Ghrelin elicited a prompt, marked increase of serum GH and PRL levels in all normal (from 1.6+/-0.6 to 52.9+/-7.8 and from 9.7+/-0.8 to 24.2+/-4.8 microg/l (means+/-S.E.M.), respectively) and acromegalic subjects (from 11.2+/-4.9 to 91.6+/-21.0 and from 42.9+/-26.1 to 113.8+/-79.0 microg/l, respectively). Both plasma ACTH and serum cortisol levels rose significantly in the controls, whereas the cortisol response was blunted in the acromegalic patients. Glucose levels rose earlier and insulin levels fell later in all subjects, with a significantly greater net insulin decrease in acromegalic than in healthy subjects (-80+/-21 vs -17+/-4 pmol/l, P<0.01). A prompt PP rise and a biphasic SS response occurred in all controls, whereas in the acromegalic group the PP response (from 26.1+/-5.0 to 92.2+/-39.0 pmol/l) and the SS response (from 11.9+/-3.0 to 19.7+/-4.0 ng/l) were quite variable. CONCLUSIONS: Ghrelin affects both pituitary and GEP hormones in acromegalic patients as in normal subjects. These findings suggest that ghrelin actions on the energy balance are mediated by complex interactive endocrine loops that involve also the gut and pancreas.